A drop in June pending home sales weighed the markets down to a lower open with the Dow falling 59 points to 15,499. Nasdaq lost 16 points to 3597.
On the upside
Synta Pharmaceuticals (Nasdaq: SNTA) announced positive preliminary results from the ENCHANT-1 clinical trial of its breast cancer treatment.
Uranium Resources (Nasdaq: URRE) will host a conference call for second quarter results on Friday, August 9, 2013.
USEC's (NYSE: USU) American Centrifuge completed its sixth milestone for Department of Energy certification.
On the downside
Shanda Games (Nasdaq: GAME) will acquire affiliates that provide user and payment platform services.
Perrigo (Nasdaq: PRGO) will pay approximately $8.6 billion in cash and stock to acquire Elan.
Desarrolladora Homex (NYSE: HXM) disappointed by falling to a loss for the second quarter as revenue plummeted.
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 2 on the NYSE and by nearly 7 to 3 on Nasdaq. The broader S&P 500 index lost 7 points to 1683.
